EP 1131102 A2 20010912 - COMBINATION OF A GABA-A ALPHA 5 INVERSE AGONIST AND COX-2 INHIBITOR, NSAID, ESTROGEN OR VITAMIN E
Title (en)
COMBINATION OF A GABA-A ALPHA 5 INVERSE AGONIST AND COX-2 INHIBITOR, NSAID, ESTROGEN OR VITAMIN E
Title (de)
KOMBINATION VON INVERSE AGONISTEN DES GABA-A ALPHA-5 REZEPTOR SUBTYPS UND COX-2 INHIBITOREN, NSAID, ÖSTROGEN ODER VITAMIN E
Title (fr)
COMBINAISON D'UN AGONISTE INVERSE DE GABA A ALPHA-5 ET D'UN INHIBITEUR DE COX-2, D'UN ANTI-INFLAMMATOIRE NON STEROIDIEN, D'UN OESTROGENE ET DE VITAMINE E
Publication
Application
Priority
- GB 9901338 A 19990121
- US 9926623 W 19991110
- US 10810598 P 19981112
Abstract (en)
[origin: WO0027382A2] Combinations of a GABAA alpha 5 inverse agonist and a COX-2 inhibitor, NSAID, estrogen or vitamin E are disclosed for treating neurodegenerative conditions such as Alzheimer's Disease.
IPC 1-7
IPC 8 full level
A61K 31/355 (2006.01); A61K 31/566 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 45/06 (2013.01); A61P 25/16 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 0027382A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0027382 A2 20000518; WO 0027382 A3 20000831; AU 1717800 A 20000529; AU 764875 B2 20030904; CA 2351057 A1 20000518; EP 1131102 A2 20010912; JP 2002529406 A 20020910
DOCDB simple family (application)
US 9926623 W 19991110; AU 1717800 A 19991110; CA 2351057 A 19991110; EP 99960268 A 19991110; JP 2000580611 A 19991110